Twist Bioscience Corporation stock rating and score history
All changes in ratings, performance and outlook tracked over time.
Twist Bioscience Corporation stock price, chart patterns and momentum
Recent price movements, trend behaviour and momentum signals based on real-time market data.
What does Twist Bioscience Corporation do? Business model and key facts
Get the full picture of Twist Bioscience Corporation: what it builds, where it operates, and how it makes money.
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Employees (FY): 923
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.
Stocks related to Twist Bioscience Corporation
Selected based on industry alignment and relative market positioning.
Events and news impacting Twist Bioscience Corporation stock
Earnings, coporate decisions and industry developments that can affect the share price.
Twist Bioscience Corporation fundamentals and technical analysis
Financial fundamentals and technicals signals combined to access stability, momentum and market direction.
